clinical trial · NCT07158437
Phase 1 Study of SL-325 in Healthy Volunteers
Healthy VolunteersSL-325Placebo (Normal Saline)
brief summary
This first-in-human study is a randomized, double-blind, placebo-controlled, single-ascending dose and multiple-ascending dose study of SL-325 in healthy volunteers.
started
Sep 1, 2025
primary completion
Jul 1, 2026
completion
Jul 1, 2026
last updated
Sep 5, 2025
official title
A Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Phase 1 Study of SL-325 in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol